Sinopharm Accord's net profit attributable to shareholders in the first half of the year was 666 million yuan, a year-on-year decrease of 10.43%
Sinopharm Accord released its semi-annual performance report for 2025, achieving operating revenue of 36.797 billion yuan in the first half of the year, a year-on-year decrease of 2.62%; net profit attributable to the parent company was 666 million yuan, a year-on-year decrease of 10.43%. The distribution segment's operating revenue was 26.783 billion yuan, a year-on-year decrease of 1.09%; net profit was 482 million yuan, a year-on-year decrease of 7.82%. The retail segment's operating revenue was 10.479 billion yuan, a year-on-year decrease of 6.46%; net profit was 17 million yuan, a year-on-year increase of 215.81%
According to the Zhitong Finance APP, Sinopharm Accord (000028.SZ) released its semi-annual performance report for 2025. In the first half of the year, the company achieved operating revenue of 36.797 billion yuan, a year-on-year decrease of 2.62%; the net profit attributable to shareholders of the listed company was 666 million yuan, a year-on-year decrease of 10.43%.
During the reporting period, the distribution segment achieved operating revenue of 26.783 billion yuan, a year-on-year decrease of 1.09%; it achieved a net profit of 482 million yuan, a year-on-year decrease of 7.82%. The slight decline in sales revenue in the distribution segment was mainly affected by changes in industry policies and intensified market competition; the increase in long-aged accounts receivable due to delayed payments from downstream customers led to an increase in the corresponding bad debt provision year-on-year, resulting in a profit decline. The retail segment (i.e., "Sinopharm Holdings Guoda Pharmacy Co., Ltd.", hereinafter referred to as "Guoda Pharmacy") achieved operating revenue of 10.479 billion yuan, a year-on-year decrease of 6.46%; it achieved a net profit of 17 million yuan, a year-on-year increase of 215.81%. The sales revenue of Guoda Pharmacy decreased year-on-year due to a combination of factors including market environment, competitive landscape, and strategic store closures; at the same time, Guoda Pharmacy continued to optimize its procurement system and business structure, enhancing profitability through measures such as accelerating the development of its own brand and increasing the proportion of centralized procurement, while focusing on improving the quality of front-end store operations, strategically closing stores, and enhancing the operational quality of individual stores, leading to a decrease in related expenses such as labor costs and store rents. Therefore, during the reporting period, the net profit of Guoda Pharmacy increased year-on-year
